method
repeat
immun
inactiv
vaccin
use
wide
increas
antibodi
protect
infecti
bronchiti
viru
ibv
howev
compar
dna
vaccin
method
usual
induc
poor
cellular
respons
present
studi
specif
pathogenfre
spf
chicken
immun
intramuscularli
dna
vaccin
carri
main
ibv
structur
gene
respect
boost
ibv
strain
inactiv
vaccin
assess
whether
new
strategi
could
enhanc
immun
respons
ibv
protect
efficaci
dna
vaccin
carri
differ
structur
gene
prime
evalu
chicken
immun
prime
day
boost
week
later
distribut
dna
vaccin
vivo
percentag
subgroup
peripher
blood
tlymphocyt
specif
igg
viru
neutral
antibodi
measur
chicken
challeng
nasalocular
rout
ibv
strain
week
booster
immun
result
demonstr
prime
dna
vaccin
encod
nucleocapsid
protein
boost
inactiv
ibv
vaccin
led
dramat
augment
humor
cellular
respons
provid
rate
immun
protect
provid
effect
approach
protect
chicken
ibv
infecti
bronchiti
viru
ibv
envelop
coronaviru
contain
unseg
singlestrand
positivesens
rna
genom
ibv
genom
encod
four
major
structur
protein
known
spike
glycoprotein
small
envelop
e
protein
membran
glycoprotein
nucleocapsid
n
protein
spaan
et
al
peng
et
al
spike
protein
cleav
produc
neutral
serotypespecif
antibodi
cell
attach
determin
locat
cavanagh
et
al
small
envelop
protein
e
mostli
embed
within
envelop
report
cytotox
tlymphocyt
ctl
epitop
yet
amino
terminu
protein
lie
outsid
virion
particl
glycosyl
n
protein
associ
kb
genom
within
viral
particl
play
import
role
structur
replic
ibv
collisson
et
al
stern
sefton
infect
ibv
reduc
perform
broiler
egg
product
cavanagh
naqi
make
sever
econom
impact
domest
commerci
poultri
industri
therefor
consider
effort
vaccin
prevent
ib
made
half
centuri
tradit
treatment
viru
infect
usual
involv
inactiv
vaccin
live
attenu
vaccin
bijlenga
et
al
tang
et
al
howev
pitfal
found
type
vaccin
inactiv
vaccin
induc
high
titer
antibodi
usual
lower
ctl
respons
arian
et
al
yang
et
al
ibv
singl
involv
inactiv
vaccin
usual
result
less
protect
chicken
cavanagh
live
attenu
vaccin
induc
humor
cellular
immun
respons
possibl
spread
live
vaccin
viru
ware
tannock
altern
develop
dna
vaccin
consid
possibl
strategi
long
last
express
period
induct
cellular
respons
woodland
safeti
wolff
et
al
howev
weak
slow
humor
respons
induc
dna
vaccin
still
problem
li
et
al
therefor
develop
effect
vaccin
schedul
practic
control
infecti
bronchiti
ib
still
requir
due
consider
primeboost
schedul
dna
vaccin
plu
inactiv
vaccin
propos
possibl
mean
induc
humor
well
cellular
respons
ramshaw
ramsay
ming
et
al
wang
et
al
howev
method
never
use
practic
ibv
purpos
present
studi
test
whether
prime
dna
vaccin
see
front
matter
elsevi
bv
right
reserv
carri
main
ibv
structur
gene
follow
boost
inactiv
ibv
vaccin
could
enhanc
immun
respons
determin
structur
gene
prime
give
best
protect
infect
respiratorypathogen
ibv
strain
china
institut
veterinari
drug
control
ivdc
propag
allanto
caviti
specif
pathogenfre
spf
embryon
chicken
egg
allanto
fluid
harvest
h
inocul
egg
infect
dose
eid
determin
inocul
serial
dilut
viru
spf
embryon
chicken
egg
spf
chicken
embryo
shandong
institut
poultri
scienc
shandong
china
hatch
hous
specif
pathogenfre
environ
laboratori
anim
resourc
facil
sichuan
univers
cell
cultur
c
carbon
dioxid
dulbecco
modifi
eagl
medium
gibco
brl
usa
supplement
fb
uml
penicillin
gml
streptomycin
ph
ib
inactiv
strain
vaccin
purchas
ivdc
plasmid
invitrogen
carlsbad
ca
usa
consist
guidanc
clinic
consider
dna
vaccin
infecti
diseas
indic
sfda
licens
dna
vaccin
use
studi
amplif
rtpcr
genbank
access
genbank
access
n
genbank
access
gene
ibv
strain
clone
express
vector
design
respect
fig
plasmid
sequenc
confirm
clone
accuraci
express
recombin
plasmid
demonstr
indirect
immunofluoresc
assay
ifa
sixwel
tissu
cultur
plate
seed
cell
well
monolay
confluent
cell
transfect
lipofectamin
contain
plasmid
empti
vector
respect
use
lipofectamin
reagent
invitrogen
carlsbad
ca
usa
thirtysix
hour
transfect
cell
wash
phosphatebuff
salin
pb
fix
aceton
min
c
wash
pb
dilut
primari
secondari
antibodi
incub
c
h
respect
primari
antibodi
use
antiserum
rabbit
ibv
secondari
antibodi
fitcconjug
goat
antirabbit
igg
sigmaaldrich
st
loui
mo
usa
cell
wash
express
recombin
plasmid
analyz
fluoresc
microscopi
plasmid
amplifi
escherichia
coli
extract
use
ammonium
acet
lysi
method
xie
et
al
purif
polyethylen
glycol
precipit
plasmid
incorpor
lipofectamin
immun
chicken
divid
random
group
n
immun
intramuscularli
day
differ
immun
strategi
list
tabl
group
five
chicken
euthan
day
day
dna
immun
tissu
collect
ground
steril
condit
order
heart
lung
liver
spleen
kidney
genom
dna
extract
tissu
use
dnazol
reagent
invitrogen
carlsbad
ca
usa
accord
manufactur
instruct
use
pcr
templat
detect
distribut
dna
vaccin
vivo
group
group
inactiv
vaccin
group
inactiv
vaccin
inactiv
vaccin
group
inactiv
vaccin
group
inactiv
vaccin
group
inactiv
vaccin
group
inactiv
vaccin
inactiv
vaccin
group
pb
pb
group
intramuscularli
inject
g
dna
vaccin
ml
inactiv
ibv
vaccin
seven
day
boost
peripher
blood
sampl
immun
chicken
collect
jugular
vein
ml
syring
preload
ml
sodium
heparin
peripher
blood
mononuclear
cell
pbmc
isol
ficollhypaqu
densiti
gradient
centrifug
adjust
cellsml
l
cell
suspens
cell
incub
h
room
temperatur
antibodi
follow
mous
antichicken
mous
antichicken
mous
antichicken
bd
bioscienc
pharmingen
san
diego
ca
usa
leukocyt
sampl
label
antibodi
sampl
process
fluoresc
activ
cell
sorter
sera
collect
everi
week
primer
vaccin
challeng
prevaccin
sera
also
collect
control
chicken
total
serum
immunoglobulin
g
igg
specif
ibv
measur
indirect
enzymelink
immunosorb
assay
elisa
test
sera
dilut
process
accord
instruct
ibv
antibodi
detect
elisa
kit
idexx
westbrook
usa
optic
densiti
nm
measur
micropl
reader
biorad
model
neg
posit
control
sera
includ
assay
total
serum
ibvspecif
igg
repres
valu
optic
densiti
titer
viru
neutral
antibodi
sera
collect
day
booster
determin
previous
describ
yin
liu
serial
dilut
serum
sampl
incub
ibv
strain
h
c
inject
l
seravir
mixtur
embryo
respect
incub
l
virusserum
mixtur
inject
allanto
caviti
spf
embryon
chicken
egg
anoth
l
untreat
viru
fluid
use
neg
control
egg
incub
c
day
dilut
inocul
ten
egg
viru
neutral
antibodi
titer
sampl
record
highest
serum
dilut
valu
protect
embryo
death
chicken
challeng
eid
ibv
strain
ml
nasalocular
rout
day
day
booster
chicken
examin
daili
week
clinic
symptom
cough
sneez
ataxia
dyspnea
death
dead
chicken
necropsi
confirm
death
due
ibv
infect
chicken
group
euthan
day
challeng
necropsi
perform
immedi
lung
tissu
collect
detect
viru
rtpcr
student
ttest
use
analyz
differ
anim
immun
group
three
indic
percentag
subgroup
peripher
blood
tlymphocyt
antibodi
respons
viru
neutraliz
antibodi
titer
pvalu
less
consid
signific
n
gene
amplifi
rtpcr
incorpor
vector
design
respect
plasmid
correct
insert
confirm
dna
sequenc
restrict
endonucleas
digest
fig
express
demonstr
transfect
cell
indirect
immunofluoresc
transfect
cell
display
fluoresc
cytoplasm
show
individu
construct
encod
n
protein
express
eukaryot
system
fig
euthan
five
chicken
group
day
dna
vaccin
immun
tissu
collect
ground
order
heart
lung
liver
spleen
kidney
steril
condit
gene
could
amplifi
pcr
extract
genom
dna
group
immun
dna
vaccin
group
group
show
neg
result
indic
distribut
test
zoogen
tissu
day
immun
peripher
blood
lymphocyt
analyz
flow
cytometri
day
day
boost
percentag
tlymphocyt
primevaccin
group
group
significantli
higher
p
group
group
percentag
two
tlymphocyt
subgroup
show
signific
differ
p
among
group
fig
result
show
detect
antibodi
ibv
antigen
chicken
reach
peak
day
booster
inocul
specif
antibodi
increas
significantli
chicken
group
much
group
group
result
also
indic
group
abl
elicit
higher
specif
antibodi
ibv
compar
group
p
booster
control
chicken
group
inject
pb
repeatedli
show
detect
specif
antibodi
fig
day
incub
embryon
chicken
egg
examin
reedmuench
method
reed
muench
use
determin
valu
viru
neutral
titer
result
summar
fig
chicken
neg
control
level
ibvspecif
neutral
antibodi
sera
collect
day
boost
neutral
titer
indic
highest
serum
dilut
protect
half
embryo
death
higher
serum
dilut
denot
higher
neutral
titer
group
group
detect
viru
neutraliz
titer
ibv
titer
group
significantli
higher
p
sampl
experiment
group
mortal
rate
infect
lung
protect
rate
challeng
chicken
ibv
summar
tabl
chicken
start
show
clinic
sign
infect
die
day
challeng
chicken
inject
pb
alon
protect
ibv
infect
develop
cough
nasal
discharg
dy
b
mortal
record
day
challeng
present
total
number
dead
chicken
group
c
percent
protect
determin
number
unaffect
chickenstot
number
chicken
pnea
death
rate
group
inject
pb
death
rate
group
lower
inactiv
ibv
immun
chicken
evalu
level
protect
differ
vaccin
strategi
challeng
lung
sampl
collect
test
rtpcr
ibv
infect
rtpcr
result
show
chicken
viru
lung
group
indic
highest
protect
rate
vaccin
group
control
chicken
ibv
posit
rtpcr
result
suggest
combin
use
dna
vaccin
express
nucleocapsid
protein
inactiv
ibv
enhanc
resist
virul
ibv
challeng
whatev
codeliveri
use
primeboost
schedul
tradit
vaccin
use
repeatedli
inactiv
ibv
alon
induc
effici
protect
immun
respons
ibv
follow
develop
dna
vaccin
vaccin
strategi
prime
dna
vaccin
combin
inactiv
vaccin
boost
reagent
new
strategi
induc
potent
immun
protect
ming
et
al
although
approach
evalu
ibv
yet
studi
provid
first
evid
efficaci
ibv
use
new
vaccin
strategi
compar
vaccin
dna
vaccin
sever
potenti
advantag
first
easi
construct
increas
safeti
immun
strategi
mimic
antigen
process
present
natur
infect
without
caus
diseas
second
fragmentbas
construct
appear
capabl
induc
potent
immun
respons
whole
inactiv
vaccin
especi
induc
cytotox
tlymphocyt
ctl
critic
control
poultri
ibv
infect
collisson
et
al
furthermor
low
level
persist
express
protein
encod
construct
plasmid
elicit
prolong
immun
stimul
also
increas
antibodi
steadili
well
tcell
affin
major
histocompat
complex
mhc
peptid
molecul
wolff
et
al
addit
coat
plasmid
lipofectamin
protect
function
plasmid
degrad
also
enhanc
immun
respons
boyl
et
al
pertmer
et
al
gregoriadi
et
al
gregoriadi
et
al
result
dna
vaccin
distribut
vivo
show
detect
target
gene
heart
lung
liver
spleen
kidney
organ
impli
potenti
long
last
express
thu
encod
protein
could
deliv
mhc
mhc
ii
antigenprocess
pathway
induc
high
level
tcell
activ
whalen
et
al
result
enhanc
immunogen
prior
challeng
investig
tlymphocyt
subgroup
indic
prime
dna
vaccin
encod
ibv
structur
gene
percentag
tlymphocyt
subgroup
group
higher
group
especi
group
p
report
tcell
respons
may
produc
directli
antivir
cytokin
well
increas
prolifer
matur
function
activ
play
critic
role
control
ibv
infect
poultri
collisson
et
al
furthermor
dna
immun
effect
elicit
better
potenti
longer
last
tlymphocyt
b
cell
immunolog
suggest
low
dose
antigen
deliveri
effect
elicit
better
antibodi
respons
memori
b
cell
bot
et
al
gonzalez
milstein
increas
tlymphocyt
group
purport
dna
vaccin
stimul
intens
cellular
immun
help
complet
elimin
viru
letelli
et
al
tian
et
al
provid
effici
way
protect
higher
antibodi
titer
also
suggest
memori
b
cell
induc
prime
dna
vaccin
due
characterist
dna
vaccin
suitabl
candid
prime
choic
booster
inactiv
vaccin
prepar
whole
viru
particl
immun
respons
induc
inactiv
ibv
vaccin
respond
whole
viru
better
capabl
choos
dna
plasmid
booster
evok
memori
b
cell
confirm
group
higher
igg
neutral
antibodi
titer
group
also
higher
elisa
neutral
antibodi
titer
higher
level
protect
ibv
observ
chicken
boost
inactiv
ibv
vaccin
group
especi
group
p
inactiv
vaccin
booster
also
consid
balanc
immun
respons
larsen
et
al
morello
et
al
could
acceler
specif
neutral
antibodi
induct
increas
tcell
respons
critic
stabil
immun
system
well
interestingli
significantli
higher
p
elisa
neutral
antibodi
titer
tlymphocyt
detect
uniqu
group
studi
may
attribut
interact
vector
encod
nucleocapsid
protein
inactiv
vaccin
encod
nucleocapsid
protein
shown
express
ctl
epitop
carboxyl
end
mhc
molecul
induc
boot
et
al
boot
et
al
seo
collisson
show
better
efficaci
combin
antibodi
control
infect
fang
lui
also
highli
conserv
nucleocapsid
protein
abund
virusderiv
protein
produc
throughout
infect
immunogen
also
induc
crossreact
antibodi
ultim
protect
chicken
viral
infect
seah
et
al
yu
et
al
previou
studi
confirm
immun
avian
coronaviru
nucleocapsid
protein
appli
dna
vaccin
induc
protect
immun
provid
cell
possibl
local
antibodi
boot
et
al
challeng
assay
also
prove
combin
use
dna
vaccin
target
nucleocapsid
protein
inactiv
vaccin
effect
contrast
group
perform
well
challeng
assay
elisa
neutral
antibodi
assay
might
due
high
variat
gene
contribut
poor
crossprotect
cavanagh
although
amount
coadminist
dna
vaccin
inactiv
vaccin
use
immun
doubl
group
effect
elicit
protect
immun
respons
much
better
p
group
singl
use
dna
vaccin
prime
inactiv
vaccin
booster
appli
suggest
supplementari
benefit
inactiv
vaccin
repeatedli
codeliv
approach
taken
togeth
sequenti
approach
prime
nucleocapsid
gene
boost
inactiv
ibv
vaccin
show
potent
immunolog
advantag
could
potenti
vaccin
strategi
provid
protect
ibv
infect
chicken
model
next
step
evalu
whether
primeboost
strategi
broiler
chicken
would
high
matern
deriv
antibodi
titer
ibv
first
week
life
